C-[1-(3-Bromo-benzenesulfonyl)-piperidin-4-yl]-methylamine hydrochloride, 95.0%, 250mg

2-(4-(Methoxycarbonyl)phenyl)acetic acid, 95.0%, 25g

6-(4-(trifluoromethyl)phenyl)nicotinaldehyde, 98+%, 5g

((3S,5R)-5-((1H-1,2,4-Triazol-1-yl)methyl)-5-(2,4-difluorophenyl)tetrahydrofuran-3-yl)methyl 4-methylbenzenesulfonate, 97%, 100mg

1-ACETYL-4-METHYLPIPERAZINE HCL, 95.0%, 1g

N-octylaniline, 97%, 5g

1-Acetyl-pyrrolidine-2-carbaldehyde, 95.0%, 250mg

2,4-Dibromo-5-fluoroaniline, 95.0%, 1g

4,4'-(Bromomethylene)bis(fluorobenzene), 95.0%, 1g

Ethyl tetrahydro-2H-pyran-4-carboxylate, 97.0%, 25g

(S)-2-(4-Chlorophenyl)piperidine, 95%, 100mg

4,4,5,5-Tetramethyl-2-(3,4,5-trifluorophenyl)-1,3,2-dioxaborolane>98.0%(GC)(T)1g

D-valine, min. 98.5%, for biochemistry, 100 g, plastic packaging.